Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Bullboard Posts
Post by Bobowskion Feb 06, 2020 6:32pm
291 Views
Post# 30654637

Going forward....

Going forward....Q2 financials (as of Nov 30) showed a good cash position (about 12 months times the monthly burn) and shares outstanding went from 38 milion to 109 million reflecting a market cap of about $45 million as of that date. Shares outstanding relected shares issued to Isracann Holdings (wholly owned by Isracann Biosciences) and CAD 51 cent financing shares coming off the hold period as at Jan 31. Share price usually comes under pressure when a hold period is coming to an end as well as for a week or two after. Note shares short came down from about 4 million at the end of Dec to about 400K at the end of Jan. Share price did come down and are now holding steady. Companies usually do not post any news during this period as it would be a waste. Look for steady exciting news to start coming out in the latter part of Feb which should drive the share price north of CAD 51 cents. How far it will go depends on how excited investors get.
Bullboard Posts